ISP-001: Sleeping Beauty Transposon-Engineered B Cells for MPS I
Clinical trial NCT05682144 · RECRUITING
Trial details
- NCT number
- NCT05682144
- Sponsor
- Immusoft of CA, Inc.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-12
- Primary completion
- 2029-06-01
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.